product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
JMJD2B (D7E6) Rabbit mAb
catalog :
8639
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D7E6
reactivity :
human
application :
western blot, immunocytochemistry, immunoprecipitation, chromatin immunoprecipitation
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 2D
Castellini L, Moon E, Razorenova O, Krieg A, von Eyben R, Giaccia A. KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage. Nucleic Acids Res. 2017;45:3674-3692 pubmed publisher
  • chromatin immunoprecipitation; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 3g
Li H, Yang X, Wang G, Li X, Tao D, Hu J, et al. KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer. Oncotarget. 2016;7:57866-57877 pubmed publisher
  • western blot; human; fig 1
Mudie S, Bandarra D, Batie M, Biddlestone J, Moniz S, Ortmann B, et al. PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia. Cell Cycle. 2014;13:3878-91 pubmed publisher
product information
SKU :
8639S
Product-Name :
JMJD2B (D7E6) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, Mk
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Chromatin Regulation / Nuclear Function
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
150
Host :
Rabbit
Target :
JMJD2B
Primary-Protein :
JMJD2B
Alt-Names :
FLJ44906,JHDM3B,JMJD2B,JmjC domain-containing histone demethylation protein 3B,Jumonji domain-containing protein 2B,KDM4B,KIAA0876,Lysine-specific demethylase 4B,jumonji domain containing 2B,lysine (K)-specific demethylase 4B
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.